Medical Devices Startups

Wearable Robotics develops exoskeletons and wearable robotic devices for motor rehabilitation and physical therapy in healthcare settings. The company's technology combines mechanical exoskeleton design with virtual reality integration to support recovery of motor functions in post-stroke patients and elderly populations.

1 investor

Wedgewood is the largest compounding pharmacy in the U.S. that exclusively serves animal health, preparing individualized medications for veterinarians and animal caregivers. The company manufactures customized treatments that cannot be obtained through standard pharmaceutical channels.

1 investor

WeInfuse provides software to streamline operations at infusion centers, helping providers manage medication delivery workflows and improve clinical outcomes. The platform serves infusion providers and their nursing staff.

1 investor

Wellford is a vertically integrated medical cannabis and pharmaceutical business operating across the UK, Germany, and Canada, serving regulated healthcare markets with cannabis-based prescription medicines, cultivation, manufacturing, and specialty pharmacy services.

1 investor

Boost manufactures lightweight, breathable breast forms designed for post-mastectomy wear, created in collaboration with breast cancer survivors and marketed as an alternative to traditional heavy silicone prosthetics. The company produces these products in Cornwall, UK, with a focus on comfort, style, and sustainability.

1 investor

Whale Imaging is a medical imaging company. The provided page offers no concrete detail about its products, technology, or customers.

1 investor

Weinnovate Biosolutions develops antimicrobial treatments and infection prevention and control solutions for healthcare providers. The company focuses on reducing hospital-acquired infections and associated hospitalization costs.

1 investor

Wicked Technologies makes the Wicked Smart Pad, a washable, reusable sensorized bed pad that detects moisture and sends real-time alerts to caregivers, along with a dashboard providing care insights. The FDA-registered Class II medical device is aimed at senior living and long-term care communities to improve incontinence monitoring and response.

1 investor

WyL provides home-based nursing and care services including visiting care, intensive home care, and medical care housing across Japan. The company serves patients with complex medical needs—including cancer, palliative care, mental health, and rare diseases—offering comprehensive support from newborn to end-of-life care.

1 investor

WillowWood manufactures prosthetic devices and components, including microprocessor-controlled knees, feet, liners, and sockets for lower and upper limb amputees. The company serves orthotic and prosthetic professionals and patients across varying activity levels and limb configurations.

1 investor

Win-Shield Devices designs and manufactures advanced personal protective equipment including face shields and respiratory devices for military, law enforcement, industrial, healthcare, and emergency response professionals. The Canadian company develops custom, high-performance protection solutions in collaboration with end-users and regulatory bodies.

1 investor

WinnCare manufactures dynamic air mattresses and overlays designed to prevent pressure ulcers in dependent patients at medium to high risk. The company serves healthcare facilities and caregivers managing patients with limited mobility.

1 investor

Winsantor is a clinical-stage biotechnology company developing treatments for peripheral neuropathies, including diabetic peripheral neuropathy and chemotherapy-induced peripheral neuropathy. The company is currently advancing its lead drug candidate, WST-057, through Phase 2 clinical trials in Canada.

1 investor

Winter Innovations develops a patented two-part needle technology and stitching solutions for orthopedic surgery. Its products are aimed at surgical use in the orthopedic medical field.

1 investor

Wobble Genomics operates an RNA sequencing platform that captures full-length RNA transcripts to identify long RNA biomarkers and novel isoforms for precision medicine. It serves pharmaceutical and diagnostics companies, supporting biomarker discovery, patient stratification, diagnostics, and therapeutic development.

1 investor

Wound Solutions AI develops WoundRounds, a point-of-care wound management and prevention platform for wound clinicians in healthcare settings. The company applies health technology innovations to improve patient outcomes and provider well-being.

1 investor

X-ZELL develops cryoimmunostaining platforms and multiplex panels for cytology laboratories, enabling extraction of multiple biomarkers from single tissue specimens while preserving samples for further testing. The company serves pathologists, oncologists, and diagnostic partners primarily in Southeast Asia with CE-marked, ISO 13485-certified reagents and workflow solutions.

1 investor

未知君 (XBiome) develops microbiome-based therapeutics and diagnostics using AI-driven bioengineering, targeting diseases including cancer immunotherapy, inflammatory conditions, and autism through live bacterial therapeutics and fecal microbiota transplantation (FMT). The company operates in China with clinical development, manufacturing, and computational biology capabilities across multiple cities.

1 investor

xDot Medical is an early-stage medical device company developing an automated vascular closure device that provides instant closure of the access site for catheter-based cardiovascular therapies.

1 investor

Xellia manufactures anti-infective pharmaceutical products with a focus on supply chain continuity and reliable availability of critical active pharmaceutical ingredients in Western markets.

1 investor

XENA provides 3D surgical roadmaps generated from standard MRI scans to guide soft-tissue surgeries, particularly gynecological procedures like endometriosis, fibroids, and adenomyosis cases. The platform uses automated organ segmentation to create pre-operative 3D maps with disease visualization and intraoperative guidance displayed in the operating room.

1 investor

Xenios AG, a Fresenius Medical Care company, develops and manufactures hardware and systems for extracorporeal heart and lung support used in intensive care medicine. It serves critically ill patients and clinical teams such as cardiac surgeons and perfusionists, with three production sites in Germany.

1 investor

Xenter develops wireless medical technologies and a medical intelligence platform that aggregates devices, medical data, and diagnostics to apply AI in medicine, with expertise in medical devices and interventional cardiology. The company operates from Salt Lake City with a global network.

1 investor

Crosslink Therapeutics develops protein engineering and cancer therapies, focusing on immunological and oncology treatments in the biopharmaceutical sector.

1 investor